Frederique Vegran

Dijon, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

IL-10 secretion by CD8 T cells orchestrates early NK cell recruitment and antitumor immunity after anti-VEGFR-2/PD-1 therapy.

IL-10 secretion by CD8 T cells orchestrates early NK cell recruitment and antitumor immunity after anti-VEGFR-2/PD-1 therapy.

Journal: Journal for immunotherapy of cancer

Published: May 30, 2026

Stearoyl-CoA desaturase-1 controls the differentiation and antitumoral function of Th9 lymphocytes.

Stearoyl-CoA desaturase-1 controls the differentiation and antitumoral function of Th9 lymphocytes.

Journal: Journal for immunotherapy of cancer

Published: December 28, 2025

The intrinsic expression of NLRP3 in Th17 cells promotes their protumor activity and conversion into Tregs.

The intrinsic expression of NLRP3 in Th17 cells promotes their protumor activity and conversion into Tregs.

Journal: Cellular & molecular immunology

Published: June 19, 2024

NR0B2 re-educates myeloid immune cells to reduce regulatory T cell expansion and progression of breast and other solid tumors.

NR0B2 re-educates myeloid immune cells to reduce regulatory T cell expansion and progression of breast and other solid tumors.

Journal: Cancer letters

Published: March 08, 2024

Development of NR0B2 as a therapeutic target for the re-education of tumor associated myeloid cells.

Development of NR0B2 as a therapeutic target for the re-education of tumor associated myeloid cells.

Journal: Cancer letters

Published: March 08, 2024

Valrubicin-loaded immunoliposomes for specific vesicle-mediated cell death in the treatment of hematological cancers.

Valrubicin-loaded immunoliposomes for specific vesicle-mediated cell death in the treatment of hematological cancers.

Journal: Cell death & disease

Published: November 14, 2023

Re-education of myeloid immune cells to reduce regulatory T cell expansion and impede breast cancer progression.

Re-education of myeloid immune cells to reduce regulatory T cell expansion and impede breast cancer progression.

Journal: bioRxiv : the preprint server for biology

Published: August 30, 2023

GTN Enhances Antitumor Effects of Doxorubicin in TNBC by Targeting the Immunosuppressive Activity of PMN-MDSC.

GTN Enhances Antitumor Effects of Doxorubicin in TNBC by Targeting the Immunosuppressive Activity of PMN-MDSC.

Journal: Cancers

Published: May 08, 2023

Editorial: Targeting glucose metabolism in cancer immunity and immunotherapy.

Editorial: Targeting glucose metabolism in cancer immunity and immunotherapy.

Journal: Frontiers in immunology

Published: February 21, 2023

Canonical and non-canonical functions of NLRP3.

Canonical and non-canonical functions of NLRP3.

Journal: Journal of advanced research

Published: August 08, 2022

Role of Cytokines and Chemokines in Angiogenesis in a Tumor Context.

Role of Cytokines and Chemokines in Angiogenesis in a Tumor Context.

Journal: Cancers

Published: April 01, 2022

Impact of Lipid Metabolism on Antitumor Immune Response.

Impact of Lipid Metabolism on Antitumor Immune Response.

Journal: Cancers

Published: March 15, 2022

Showing 1-12 of 52

Last Updated: 09/26/2026